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1. Introduction 
The genus Helicobacter contains 35 named species and numerous provisionally named 
species. It is likely that several novel Helicobacter species await discovery. Members of this 
genus are microaerobic, have a fusiform or curved to spiral rod morphology and are motile 
by flagella that vary in number and location among different species (Vandamme et al., 
1990). All known Helicobacters live in human and animal hosts, where colonization occurs 
primarily in the gastrointestinal tract. The type species, Helicobacter pylori (H. pylori), was 
isolated from the stomach of humans and has been associated with a variety of gastric 
anomalies including gastritis, peptic ulcer disease, gastric carcinoma, and gastric mucosa-
associated lymphoma (Parsonnet, 1998). Like H. pylori, other species of Helicobacter have also 
been shown to colonize the stomach and cause disease in animals. Gastric colonizers include 
H. felis, H. mustelae, H. acinonychis, H. bizzozeronii, H. heilmannii, H. salomonis, and a recently 
isolated novel Helicobacter sp. of dolphins (Hodzic et al., 2001). Several species of Helicobacter 
have been identified in rodents, including the species H. hepaticus, H. bilis, H. muridarum, 
H. aurati, H. cinaedi, H. cholecystus, H. trogontum, H. rodentium, and a bacterium 
morphologically resembling H. Flexispira taxon 8 (formerly Flexispira rappini) (Hodzic et al., 
2001). Evidence is accumulating that especially pigs, dogs, and cats constitute reservoir 
hosts for gastric Helicobacter species with zoonotic potential. 
2. History of Helicobacter research 
The first well-known report of gastric Helicobacters was by Bizzozero in Turin in 1893 
(Bizzozero, 1893). Bizzozero was a well-known anatomist, famous already for his proof that 
all dividing cells required cell nuclei (Castiglioni, 1947). In his anatomical observations of 
the gastric mucosa of dogs, Bizzozero reported "spirochetes" inhabiting the gastric glands 
(Figura & Orderda, 1996) and even the canaliculi of the parietal cells. In hand-drawn color 
illustrations, Bizzozero showed gram-negative organisms with approximately 10 
wavelengths within the parietal cells and gastric glands. We now know these organisms 
variously identified as H. canis, H. felis (Lee et al., 1988), and/or H. heilmannii (Heilmann & 
Borchard, 1991). Bizzozero's work was extended by Salomon, who was able to propagate 
these spiral organisms in mouse stomachs after feeding ground-up gastric mucosa from cats 
and dogs to his mouse colony (Salomon, 1896). Salomon's work was a precursor to current 
studies where the H. felis-infected mouse is an important model in vaccine and therapeutic 
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studies of Helicobacter eradication (Chen et al., 1995). Warren had observed patients with 
spiral organisms on their gastric mucosa since 1979 and had documented the inflammation 
associated with the bacteria by the time he and Marshall began a concerted attempt to study 
the organisms in patients with various upper gastrointestinal symptoms. After August 1981, 
the team studied patients attending for endoscopy and was able to demonstrate the gram-
negative bacteria on Gram stains but could not culture them at that time. They tentatively 
treated one patient with tetracycline and were able to observe a decrease in the number of 
neutrophils in the gastric mucosa as well as apparent disappearance of the bacteria. They 
recognized, however, that anecdotal evidence of the bacteria's role in gastric inflammation 
was of little value and therefore commenced a study in 100 consecutive endoscopy patients 
to try to culture the bacteria, as well as determine their association with gastritis and/or 
other clinical syndromes. Initially, they did not focus specifically on the etiology of peptic 
ulcer disease, although they were aware that gastritis was strongly associated with 
duodenal and gastric ulcers, as well as with gastric cancer (Warren & Marshall, 1983). 
3. Classification of Helicobacter species 
The genus Helicobacter contains 35 named species and numerous provisionally named 
species. It is likely that several novel Helicobacter species await discovery. Members of this 
genus are microaerobic, have a fusiform or curved to spiral rod morphology and are motile 
by flagella that vary in number and location among different species (Vandamme et al., 
1990). All known Helicobacters live in human and animal hosts, where colonization occurs 
primarily in the gastrointestinal tract. The type species, H. pylori, was isolated from the 
stomach of humans and has been associated with a variety of gastric anomalies including 
gastritis, peptic ulcer disease, gastric carcinoma, and gastric mucosa-associated lymphoma 
(Parsonnet, 1998). Like H. pylori, other species of Helicobacter have also been shown to 
colonize the stomach and cause disease in animals. Gastric colonizers include H. felis, 
H. mustelae, H. acinonychis, H. bizzozeronii, H. heilmannii, H. salomonis, and a recently isolated 
novel Helicobacter sp. of dolphins (Hodzic et al., 2001). Several species of Helicobacter have 
been identified in rodents, including the species H. hepaticus, H. bilis, H. muridarum, H. aurati, 
H. cinaedi, H. cholecystus, H. trogontum, H. rodentium, and a bacterium morphologically 
resembling Helicobacter Flexispira taxon 8 (formerly Flexispira rappini) (Hodzic et al., 2001). A 
number of Helicobacter species may confound experimental data because of their association 
with disease progressing in various kinds of animals (Chin et al., 2000, Ward et al., 1994, 
Eaton et al., 1996). H. hepaticus and H. bilis were initially reported as pathogens associated 
with hepatitis and inflammatory bowel diseases (Shomer et al., 1997, Ward et al., 1996), and 
H. typhlonicus caused proliferative typhlocolitis in SCID mice ( Franklin 1999). H. suncus was 
isolated from house musk shrews as a pathogenic agent (Goto et al., 2000). 
Most routine laboratories apply the same basic biochemical tests for the identification and 
differentiation of all Campylobacter-like organisms and would fail to identify many 
Helicobacter species. Although the number of Helicobacter species encountered in human 
clinical samples is fairly small, the lack of application of highly standardized procedures 
and the well-known biochemical inertness of Campylobacter-like organisms render 
biochemical identification of all of these bacteria very difficult. Whereas Arcobacter strains 
can be differentiated from Campylobacter and Helicobacter strains by their ability to grow in 
air and at low temperature (Vandamme et al., 1991), there are no clear biochemical 
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characteristics to separate the genus Helicobacter from the genus Campylobacter. Theoretically, 
one has to differentiate over 35 validly named species and subspecies, as well as various 
unnamed taxa. An overview of biochemical and other methods to differentiate 
Campylobacter and Arcobacter species was described earlier (Vandamme, 2000). A summary 
of the characteristics of cultivated Helicobacter species shows that discrimination between 
some species may rely on only one differential feature. Moreover, some species, notably H. 
pylori and H. acinonychis, and H. felis and H. bizzozeronii, cannot be differentiated with 
conventional phenotypic tests.  
4. Clinical sequels of Helicobacter infection 
Helicobacter pylori (H. pylori) is a Gram-negative, spiral-shaped, microaerophilic bacterium 
that infects the human gastric mucosa (Warren and Marshall, 1983). Chronic infection is 
thought to be associated with chronic active gastritis, peptic ulcer and gastric malignancies, 
such as mucosa-associated B cell lymphoma and adenocarcinoma (NIH, 1994). In particular, 
this organism has been categorized as a class I carcinogen by the World Health Organization 
(International Agency for Research on Cancer, 1994) and previous studies have confirmed 
that long-term infection with H. pylori induces adenocarcinoma in Mongolian gerbils 
(Honda et al., 1998; Watanabe et al., 1998). The association between H. pylori and gastric 
cancer has been explained by two possible mechanisms.  
Gastric mucosal infection with H. pylori is accompanied by infiltration of neutrophils, and 
activated inflammatory cells are known to produce oxygen radicals (Evans et al., 1995; 
Ramarao et al., 2000). Oxygen radicals are known as inducers and initiators because they 
cause direct DNA damage (Clemens, 1991), but the relationship of these radicals with the 
onset of gastric cancer has not been sufficiently explored. Ammonia/ammonium 
concentrations increase in the gastric mucosa due to infection with H. pylori, and Tsujii et al. 
have found that ammonia acts as a promoter in a rat model of gastric cancer induced by N-
methyl-N-nitro-N-nitrosoguanidine (MNNG) (Tsujii et al., 1992). To consider the association 
between H. pylori infection and the onset of diffuse type of gastric cancer, unlike intestinal 
type gastric cancer, the process from infection with H. pylori through gastric mucosal 
atrophy, intestinal metaplasia, and development of cancer must be excluded (Correa et al., 
1994; Fay et al., 1994). Direct evidence must therefore be found to indicate progression from 
infection with H. pylori through persistent inflammatory cell infiltration resulting in DNA 
damage by oxygen radicals, point mutations of genes, and finally carcinogenesis. 
5. Host ranges of Helicobacters 
Since H. muridarum was first reported in the intestinal mucosal of mice and rats (Lee 1992), 
additional Helicobacter species have been isolated from laboratory animals. Several 
Helicobacter species such as H. hepaticus (Fox 1994), H. muridarum, H. bilis (Fox et al., 1995), H. 
rodentium (Shen et al., 1997), Flexispira rappini (Schauer et al., 1993), H. typhlonicus (Franklin 
et al., 1999) have been identified in rodents. The genus Helicobacter contains 24 named 
species and numerous provisionally named species. It is likely that several novel Helicobacter 
species await discovery. Members of this genus are microaerobic, have a fusiform or curved 
to spiral rod morphology and are motile by flagella that vary in number and location among 
different species (Vandamme et al., 1990). All known Helicobacters live in human and animal 
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hosts, where colonization occurs primarily in the gastrointestinal tract. The type species, H. 
pylori, was isolated from the stomach of humans and has been associated with a variety of 
gastric anomalies including gastritis, peptic ulcer disease, gastric carcinoma, and gastric 
mucosa-associated lymphoma (Parsonnet, 1998). Like H. pylori, other species of Helicobacter 
have also been shown to colonize the stomach and cause disease in animals. Gastric 
colonizers include H. felis, H. mustelae, H. acinonychis, H. bizzozeronii, H. heilmannii, 
H. salomonis, and a recently isolated novel Helicobacter sp. of dolphins (Hodzic et al., 2001). 
Several species of Helicobacter have been identified in rodents, including the species 
H. hepaticus, H. bilis, H. muridarum, H. aurati, H. cinaedi, H. cholecystus, H. trogontum, 
H. rodentium, and a bacterium morphologically resembling H. Flexispira taxon 8 (formerly 
Flexispira rappini) (Hodzic et al., 2001). 
6. Transmission of Helicobacters 
In-depth knowledge of the transmission patterns may constitute important information for 
future intervention strategies. In the absence of consistent and verified environmental 
reservoirs, a predominantly person-to-person transmission has been postulated. H. pylori 
infection is associated with poor living conditions, and possible transmission routes are 
fecal-oral, oral-oral, or gastro-oral, but firm evidence is lacking (Torres et al., 2000). Young 
children are particularly vulnerable to infection by transmission of H. pylori from their 
infected parents, especially infected mothers (Rothenbacher et al., 1999), and it is generally 
believed that such transmission is influenced by socio-economic status. However, little is 
known about how and when maternal transmission occurs during perinatal period, 
especially whether this occurs before or after parturition. In the present study, we examined 
these issues in an experimental murine model, Mongolian gerbil model that have been 
reported as a most optimal laboratory animal model to study H. pylori in vivo (Hirayama et 
al., 1996). 
In the previous study, Lee & Kim (2006) examined these issues in an experimental murine 
model, Mongolian gerbil model that have been reported as a most optimal laboratory 
animal model to study H. pylori. Pregnant Mongolian gerbils, infected experimentally with 
H. pylori, were divided as four groups. Following the experimental design, the stomachs of 
the mother and litters were isolated and assessed for transmission of H. pylori at prenatal 
period, parturition day, 1-week old age and 3-week old age respectively. Bacterial culture 
and polymerase chain reaction (PCR) was used to examine the presence of transmitted H. 
pylori. All litters showed no transmission of H. pylori during pregnancy and at parturition 
day. However, they reveled 33.3% and 69.6 % at 1-week old age and 3-week old age 
respectively by PCR. These results suggested that vertical infection during prenatal period 
or delivery procedure is unlikely as a route of mother-to-child H. pylori infection. It might be 
acquired H. pylori through breast-feeding, contaminating saliva and fecal-oral during co-
habitat (Lee & Kim, 2006).  
Half of the world's population is estimated to be infected with H. pylori and the infection is 
mainly acquired in early childhood but the exact routes of transmission remain elusive. 
Infected mothers are generally considered to be the main source of the pathogen 
(Weyermann  et al., 2006; Escobar & Kawakami, 2004; Rothenbacher et al., 2002). The 
epidemiology of H. pylori infection is variable, with prevalence being significantly higher 
and incident infection occurring earlier in developing countries compared with developed 
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countries (Frenck & Clemens 2003; Ahuja & Sharma, 2002; Graham et al., 1991). There is an 
obvious public health impact of H. pylori infection and thus, to design targeted and cost-
effective prevention strategies, elucidation of the mode of transmission for this bacteria is 
crucial (Fendrick et al., 1999). It is known that H. pylori infection is typically acquired in early 
childhood and usually persists throughout life unless specific treatment is applied (Crone &  
Gold 2004). Definitive modes of transmission have not yet been characterized and the 
principal reservoir appears to be humans. Person-to-person transmission via fecal-oral, oral-
oral and gastro-oral routes have been proposed (Mladenova et al., 2006). Numerous studies 
also indicate low socioeconomic status, including domestic overcrowding in childhood, as 
major risk factors for higher infection prevalence rates (Frenck & Clemens 2003). Little is 
known about when and how often maternal transmission of H. pylori occurs during 
perinatal stage. In the previous study, Lee & Kim (2006) examined these issues in an 
experimental murine model.  
The results of the vertical-transmission experiment indicated that vertical transmission of H. 
pylori was not occurred at pregnant and delivery staged. However, they reveled 33.3% and 
69.6 % at lactating and weaning stage respectively. Recent epidemiological studies in 
humans suggest that the acquisition of H. pylori occur during childhood. For example, 
Rothenbacher et al (2000) reported that H. pylori acquisition seems to occur mainly between 
the first and second year of life: that is, after the age of weaning. Our results are in 
agreement with this report. Also, Rothenbacher et al (2000) reported that infected parents, 
especially infected mothers, play a key role in the transmission of H. pylori within families. 
Maternal contact behaviour during the breastfeeding period may be responsible for the high 
frequency of maternal transmission (Kurosawa et al., 2000). Our results also showed that the 
maternal-transmission of H. pylori was not observed during pregnancy and delivery stage, 
but detected at lactating and weaning stage. On the basis of these findings, vertical infection 
during pregnancy or at delivery is unlikely as a route of mother-to-child H. pylori infection. 
Lee & Kim (2006) suggested that H. pylori infection of transplacental route during pregnancy 
might not be occurred and that H. pylori transmission by discharges of uterine or vagina, 
obstetric delivery tract, during parturition might not be occurred. It might be acquired H. 
pylori through breast-feeding, contaminating saliva and fecal-oral during co-habitat. 
7. Diagnostic methods of Helicobacters 
To detect Helicobacter species, serologic tests (Livingston et al., 1997), the culture method 
(Russel et al., 1995), and the PCR (Engstrand et al., 1992) have been used. Serologic test may 
be not available for animal screening because of absence of available species-specific 
antibodies against Helicobacter species. Also, culture assay is labor-intensive. It has been 
reported that PCR assays is easy and useful method and can be performed even on feces as a 
noninvasive means of rapidly screening large numbers of animals for Helicobacter species 
(Beckwith et al., 1997). However, those kinds of PCR assays requires multiple assays 
because of a lot of Helicobacter species (Grehan et al., 2002). There is no doubt that a 
bacteriological culture is the best method for diagnosing a bacterial infection. However, it is 
not easy to cultivate Helicobacters because the specimens are usually obtained from several 
different locations by biopsy or necropsy. In addition, the sensitivity of the culture-isolation 
method is low (Hammar et al., 1992). Therefore, a culture is not considered to be the most 
practical diagnostic method. As a result, the CLO test and staining methods are preferred in 
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many clinical laboratories. Nonetheless, they also have problems such as accuracy of 
species-specific identification (Megraud, 1997). PCR which is a specific and sensitive 
molecular method for detecting Helicobacter DNA, can supplement the above methods. 
However, PCR methods using species-specific primers require multiple assays because of a 
lot of Helicobacter species (Grehan et al., 2002). In this study, the RNA polymerase ß-subunit-
coding gene (rpoB) was used for the detection of novel Helicobacter species by a simple PCR 
analysis. rpoB is an important transcription apparatus in all microorganisms. Because this 
region is highly conserved, this rpoB DNA PCR could be used as a consensus PCR analysis 
method to detect Helicobacter species. Therefore, it is clear that PCR methods targeting a 
stable gene such as rpoB would give more reliable results.  Mutiple PCR assays using 
Helicobacter species-specific primers may be considered an expensive, laborious, and thus 
impractical procedure for many samples in clinical laboratory settings. On the other hand, 
this consensus PCR can be used alone without multiple assays. Therfore, the cost, which is 
higher than those of other methods, including culture, will be reduced. Helicobacter species 
may be identified in this single PCR and the presence of a novel species may be detected. 
Fecal samples may be stored at room temperature for up to a week without affecting the 
outcome of PCR for Helicobacter species (Beckwith et al., 1997). Therefore, monitoring of 
Helicobacter infection could be conducted very easily by this consensus PCR with feces. In 
the previous study, the consensus PCR using rpoB primers was able to detect successfully 
Helicobacter species (Kim & Kim, 2004). A set of primers (HF, 5'-ACTTTAAACGCA 
TGAAGATAT-3'; and HR, 5'-ATATTTTGACCTTCTGGGGT-3') was used to amplify rpoB 
DNA (458 bp) encompassing the Rifr region. Amplification of rpoB DNAs (458 bp) from 
Helicobacter species PCR products was electrophoresed on a 1.2% agarose gel. The PCR 
products (458 bp) were observed from the Helicobacter species such as H. felis, H. cinaedi, H. 
mustelae, H. hepaticus, H. pylori ATCC43504, H. pylori ATCC 43579, H. pylori ATCC 43619, H. 
pylori ss1, H. pylori isolate. There was no amplification from other bacteria such as E. coli, 
Bacilus subtilis, Corynebacterium diphtheriae, Haemophilus influenzae, Moraxella catarrhalis, 
Enterococcus faecalis, suggesting that the primers (HF and HR) are Helicobacter specific. This 
consensus PCR will be useful and effective for monitoring Helicobacter species including 
human and animals and could be used for detection of a new Helicobacter species by 
combination with partial sequencing (Kim & Kim, 2004). 
8. Preventive and therapeutic methods of Helicobacters 
Various pharmacological regimens have been studied in the treatment of H. pylori infection. 
Antibiotics (Fera et al., 2001), proton–pump inhibitors (Park et al., 1996), H2-blockers (Sorba 
et al., 2001), and bismuth salts (Midolo et al., 1997) are suggested standard treatment 
modalities, which are typically combined in dual, triple and quadruple therapy regimens in 
order to eradicate H. pylori infection (Worrel et al., 1998). Some problems may arise upon 
administration of these eradication regimens, i.e. the cost (Worrel et al., 1998), the efficacy of 
antibiotics regarding the pH (for instance, amoxicillin is most active at a neutral pH and 
tetracycline has greater activity at a low pH) (Worrel et al., 1998) and resistance to the 
antibiotics (Ferrero et al., 2000). However, above 15% of the patients undergoing such drug 
regimens experienced therapeutic failure (Worrel et al., 1998). 
Hence, numerous studies have concentrated on the eradication of H. pylori infection using 
traditional herbal medicines. Garlic and Pteleopsis extracts exhibited weak and modest, 
respectively, anti-H. pylori activity (Germano et al., 1998). Fifty-four Chinese herbs were 
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screened for anti-H. pylori activity, exhibiting Rheum palmatum, Rhus javanica, Coptis japonica 
and Eugenia caryophyllata strong anti-H. pylori activity (Bae et al., 1998). Cranberry juice 
possesses modest anti-H. pylori activity (Burger et al., 2000). The anti-H. pylori activities of 
Aristolochia paucinervis, black myrobalan and cinnamon were also examined (Gadhi et al., 
2001). Anti-H. pylori compounds from the Brazilian medicinal plant Myroxylon peruiferum have 
successfully isolated (Ohsaki  1999). Extracts and fractions from seven Turkish plants were also 
demonstrated to elicit anti-H. pylori activity (Yesilada et al., 1999). The leaves, roots and stems 
of Korean and Japanese wasabi exhibited bactericidal activities against H. pylori, having the 
leaves the highest bactericidal activity (Shin et al., 2004). In addition, some flavonoids and 
isoflavonoids isolated from licorice such as licochalcone A, licoisoflavone B, and gancaonols 
have been reported to exhibit inhibitory activities against H. pylori (Fukai et al., 2002). 
Lee et al (2010) conducted the study of anti-H. pylori efficacy with 81 folk medicinal plants. 
They confirmed that 3 herbal compounds, Melia azedarach, Cinnamomum cassia and Magnolia 
officinalis showed an antibiotic effect on H. pylori infection. It could be a promising native 
herb treatment for patients with gastric complaints including gastric ulcer caused by H. 
pylori. These results will be able to develop the therapeutics against H. pylori infection. Melia 
azedarach, Cinnamomum cassia and Magnolia officinalis will be useful to treat H. pylori infected 
patients with high therapeutic efficacy and safety (Lee et al., 2010). 
9. Helicobacters as an emerging new zoonotic pathogen 
The genus Helicobacter contains at least 24 named species and an additional 35 or more novel 
Helicobacters wait formal naming (Fox, 2002). Members of this genus are microaerobic, have 
a fusiform or curved to spiral rod morphology and are motile by flagella that vary in 
number and location among different species (Vandamme et al., 1990). All known 
Helicobacters live in human and animal hosts, where colonization occurs primarily in the 
gastrointestinal tract. The type species, H. pylori, was isolated from the stomach of humans 
and has been associated with a variety of gastric anomalies including gastritis, peptic ulcer 
disease, gastric carcinoma, and gastric mucosa-associated lymphoma (Parsonnet, 1998). Like 
H. pylori, other species of Helicobacter have also been shown to colonize the stomach and 
cause disease in animals. Gastric colonizers include H. felis, H. mustelae, H. acinonychis, H. 
bizzozeronii, H. heilmannii, H. salomonis, and a recently isolated novel Helicobacter sp. of 
dolphins (Hodzic et al., 2001). The initial interest in animal Helicobacters arose from the need 
for a suitable animal model for studying H. pylori infection, and subsequently from an 
ecological perspective (Fox et al., 1997; Lee et al., 1988). However, there have been recent 
concerns regarding the potential of animals, notably domestic pets, to be a source of 
zoonotic Helicobacter infection. Dogs and cats used for biomedical research have been 
occasionally found to harbor H. pylori strains (Handt et al., 1995), while H. felis has been 
implicated as a potential human pathogen in a few cases (Wegmann et al., 1991). H. pylori 
has also been found in pet animals, and it can promote gastritis when introduced into 
specific-pathogen-free cats. The significance of this infection as a cause of gastritis in pet 
dogs and cats is nevertheless unclear. The main gastric Helicobacter species in dogs and cats 
are primarily H. heilmannii (formerly "Gastrospirillum hominis") and H. felis. These two species 
are collectively referred to as gastric Helicobacter-like organisms (GHLO) because they 
cannot be distinguished by light microscopy. So far, H. heilmannii has not been reliably 
cultured in vitro. 
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10. Conclusions 
Clinical symptoms associated with non-H. pylori Helicobacters in humans can be 
characterized by atypical complaints such as acute or chronic epigastric pain and nausea. 
Other aspecific symptoms include hematemesis, recurrent dyspepsia, irregular defecation 
frequency and consistency, vomiting, heartburn, and dysphagia, often accompanied by a 
decreased appetite. Evidence is accumulating that especially pigs, dogs, and cats constitute 
reservoir hosts for gastric Helicobacter species with zoonotic potential. The recent successes 
with in vitro isolation of these fastidious microorganisms from domestic animals open new 
perspectives for developing typing techniques that can be directly applied on gastric 
biopsies from humans. These techniques should make it possible to determine whether 
animal and human strains belonging to the same Helicobacter species are clonally related. 
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